Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis - PubMed
Review
. 2018 Mar;67(3):430-440.
doi: 10.1136/gutjnl-2016-313589. Epub 2017 Feb 23.
Affiliations
- PMID: 28232473
- DOI: 10.1136/gutjnl-2016-313589
Free article
Review
Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis
Leonardo H Eusebi et al. Gut. 2018 Mar.
Free article
Abstract
Objectives: Gastro-oesophageal reflux symptoms are common in the community, but there has been no definitive systematic review and meta-analysis of data from all studies to estimate their global prevalence, or potential risk factors for them.
Design: Medline, Embase and Embase Classic were searched (until September 2016) to identify population-based studies that reported the prevalence of gastro-oesophageal reflux symptoms in adults (≥15 years); gastro-oesophageal reflux was defined using symptom-based criteria or questionnaires. The prevalence was extracted for all studies, and according to the criteria used to define it. Pooled prevalence, according to study location and certain other characteristics, OR and 95% CIs were calculated.
Results: Of the 14 132 citations evaluated, 102 reported the prevalence of gastro-oesophageal reflux symptoms in 108 separate study populations, containing 460 984 subjects. Prevalence varied according to country (from 2.5% in China to 51.2% in Greece) and criteria used to define gastro-oesophageal reflux symptoms. When only studies using a weekly frequency of heart burn or regurgitation to define presence were considered, pooled prevalence was 13.3% (95% CI 12.0% to 14.6%). Prevalence was higher in subjects ≥50 years (OR 1.32; 95% CI 1.12 to 1.54), smokers (OR 1.26; 95% CI 1.04 to 1.52), non-steroidal anti-inflammatory drug (NSAID)/aspirin users (OR 1.44; 95% CI 1.10 to 1.88) and obese individuals (OR 1.73; 95% CI 1.46 to 2.06).
Conclusions: The prevalence of gastro-oesophageal reflux symptoms varied strikingly among countries, even when similar definitions were used to define their presence. Prevalence was significantly higher in subjects ≥50 years, smokers, NSAID users and obese individuals, although these associations were modest.
Keywords: GASTROESOPHAGEAL REFLUX DISEASE; META-ANALYSIS.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Eusebi LH, Telese A, Cirota GG, Haidry R, Zagari RM, Bazzoli F, Ford AC. Eusebi LH, et al. Aliment Pharmacol Ther. 2021 May;53(9):968-976. doi: 10.1111/apt.16321. Epub 2021 Mar 11. Aliment Pharmacol Ther. 2021. PMID: 33705573 Review.
-
Eusebi LH, Cirota GG, Zagari RM, Ford AC. Eusebi LH, et al. Gut. 2021 Mar;70(3):456-463. doi: 10.1136/gutjnl-2020-321365. Epub 2020 Jul 30. Gut. 2021. PMID: 32732370
-
Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR 3rd, Rodriguez-Artalejo F. Diaz-Rubio M, et al. Aliment Pharmacol Ther. 2004 Jan 1;19(1):95-105. doi: 10.1046/j.1365-2036.2003.01769.x. Aliment Pharmacol Ther. 2004. PMID: 14687171
-
GBD 2017 Gastro-oesophageal Reflux Disease Collaborators. GBD 2017 Gastro-oesophageal Reflux Disease Collaborators. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):561-581. doi: 10.1016/S2468-1253(19)30408-X. Epub 2020 Mar 13. Lancet Gastroenterol Hepatol. 2020. PMID: 32178772 Free PMC article.
-
Lovell RM, Ford AC. Lovell RM, et al. Am J Gastroenterol. 2012 Dec;107(12):1793-801; quiz 1802. doi: 10.1038/ajg.2012.336. Epub 2012 Oct 2. Am J Gastroenterol. 2012. PMID: 23032982 Review.
Cited by
-
Tong MH, Zhang MJ, Wang LX, Zhang ZF, Duan ZJ. Tong MH, et al. Sci Rep. 2024 Aug 6;14(1):18269. doi: 10.1038/s41598-024-69253-2. Sci Rep. 2024. PMID: 39107491 Free PMC article.
-
Wu G, Liu Y, Ning D, Zhao M, Li X, Chang L, Hu Q, Li Y, Cheng L, Huang Y. Wu G, et al. BMC Med. 2024 Aug 7;22(1):323. doi: 10.1186/s12916-024-03526-5. BMC Med. 2024. PMID: 39113061 Free PMC article.
-
Liu X, Yu H, Yan G, Sun M. Liu X, et al. Eur J Nutr. 2024 Dec;63(8):3075-3091. doi: 10.1007/s00394-024-03491-y. Epub 2024 Sep 6. Eur J Nutr. 2024. PMID: 39240314
-
Chen J, Zhang J, Ma X, Ren Y, Tang Y, Zhang Z, Ye W, Zhang X, Lin Z, Wang L, Li Z. Chen J, et al. PLoS One. 2023 Dec 11;18(12):e0294771. doi: 10.1371/journal.pone.0294771. eCollection 2023. PLoS One. 2023. PMID: 38079405 Free PMC article.
-
Zhang S, Jiang Q, Mu X, Wang Z, Liu S, Yang Z, Xu M, Ren X, Wang Y. Zhang S, et al. Medicine (Baltimore). 2020 Jul 24;99(30):e21318. doi: 10.1097/MD.0000000000021318. Medicine (Baltimore). 2020. PMID: 32791724 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical